抗生物質療法 - 概要

The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).

International journal of antimicrobial agents·2006

Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.

Expert opinion on investigational drugs·2005

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

The Journal of antimicrobial chemotherapy·1998

Empiric therapy in lower respiratory tract infection--an ongoing challenge.

Journal of chemotherapy (Florence, Italy)·1997

Tempting fate: control of communicable disease in England.

BMJ (Clinical research ed.)·1993

Safety of fleroxacin in clinical trials.

The American journal of medicine·1993

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae.

Cureus·2026

Drechslerosporium cornellii gen. et sp. nov. within the Basidiobolaceae exhibiting unique conidial discharge and digitate chlamydospores.

MycoKeys·2026

Humicola ovoideum sp. nov. and Pseudohumicola obscura sp. nov., Two Novel Chaetomiaceae Species Reported in Korea.

Mycobiology·2026

Multidimensional interaction mechanisms and engineering applications of microalgae-fungal microorganism symbiotic systems.

AIMS microbiology·2026

Plastisphere-biofouling nexus: a systematic and bibliometric synthesis of emerging microbial assemblages on microplastics in coastal waters.

Biofouling·2026

Bacteria Colonization is Associated with Inflammation-Antigen Presentation Imbalance in Myeloid Cells and Tumor Microenvironment Features in Melanoma.

Immunological investigations·2026

関連する実験動画

抗生物質療法 - 概要

関連する概念動画

The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).

Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

Empiric therapy in lower respiratory tract infection--an ongoing challenge.

Tempting fate: control of communicable disease in England.

Safety of fleroxacin in clinical trials.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae.

<i>Drechslerosporium cornellii</i> gen. et sp. nov. within the Basidiobolaceae exhibiting unique conidial discharge and digitate chlamydospores.

<i>Humicola ovoideum</i> sp. nov. and <i>Pseudohumicola obscura</i> sp. nov., Two Novel Chaetomiaceae Species Reported in Korea.

Multidimensional interaction mechanisms and engineering applications of microalgae-fungal microorganism symbiotic systems.

Plastisphere-biofouling nexus: a systematic and bibliometric synthesis of emerging microbial assemblages on microplastics in coastal waters.

Bacteria Colonization is Associated with Inflammation-Antigen Presentation Imbalance in Myeloid Cells and Tumor Microenvironment Features in Melanoma.

関連する実験動画

抗生物質療法 - 概要

関連する概念動画

関連記事